chr22-50068590-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015166.4(MLC1):c.772-35C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.147 in 1,604,718 control chromosomes in the GnomAD database, including 18,499 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.12 ( 1278 hom., cov: 31)
Exomes 𝑓: 0.15 ( 17221 hom. )
Consequence
MLC1
NM_015166.4 intron
NM_015166.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.44
Publications
7 publications found
Genes affected
MLC1 (HGNC:17082): (modulator of VRAC current 1) The function of this gene product is unknown; however, homology to other proteins suggests that it may be an integral membrane transporter. Mutations in this gene have been associated with megalencephalic leukoencephalopathy with subcortical cysts, an autosomal recessive neurological disorder. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
MLC1 Gene-Disease associations (from GenCC):
- megalencephalic leukoencephalopathy with subcortical cysts 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Myriad Women’s Health
- megalencephalic leukoencephalopathy with subcortical cystsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 22-50068590-G-A is Benign according to our data. Variant chr22-50068590-G-A is described in ClinVar as Benign. ClinVar VariationId is 262460.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.219 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MLC1 | NM_015166.4 | c.772-35C>T | intron_variant | Intron 9 of 11 | ENST00000311597.10 | NP_055981.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MLC1 | ENST00000311597.10 | c.772-35C>T | intron_variant | Intron 9 of 11 | 1 | NM_015166.4 | ENSP00000310375.6 | |||
| MLC1 | ENST00000395876.6 | c.772-35C>T | intron_variant | Intron 9 of 11 | 1 | ENSP00000379216.2 | ||||
| MLC1 | ENST00000483836.1 | n.129-35C>T | intron_variant | Intron 2 of 4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.122 AC: 18576AN: 151808Hom.: 1278 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
18576
AN:
151808
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.138 AC: 34372AN: 248190 AF XY: 0.145 show subpopulations
GnomAD2 exomes
AF:
AC:
34372
AN:
248190
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.149 AC: 216808AN: 1452792Hom.: 17221 Cov.: 35 AF XY: 0.152 AC XY: 109646AN XY: 722780 show subpopulations
GnomAD4 exome
AF:
AC:
216808
AN:
1452792
Hom.:
Cov.:
35
AF XY:
AC XY:
109646
AN XY:
722780
show subpopulations
African (AFR)
AF:
AC:
2407
AN:
33004
American (AMR)
AF:
AC:
6116
AN:
44470
Ashkenazi Jewish (ASJ)
AF:
AC:
2176
AN:
25932
East Asian (EAS)
AF:
AC:
3980
AN:
39366
South Asian (SAS)
AF:
AC:
19079
AN:
85938
European-Finnish (FIN)
AF:
AC:
5070
AN:
51676
Middle Eastern (MID)
AF:
AC:
795
AN:
5330
European-Non Finnish (NFE)
AF:
AC:
168689
AN:
1107310
Other (OTH)
AF:
AC:
8496
AN:
59766
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.545
Heterozygous variant carriers
0
9860
19720
29581
39441
49301
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6144
12288
18432
24576
30720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.122 AC: 18582AN: 151926Hom.: 1278 Cov.: 31 AF XY: 0.123 AC XY: 9117AN XY: 74222 show subpopulations
GnomAD4 genome
AF:
AC:
18582
AN:
151926
Hom.:
Cov.:
31
AF XY:
AC XY:
9117
AN XY:
74222
show subpopulations
African (AFR)
AF:
AC:
3110
AN:
41474
American (AMR)
AF:
AC:
2668
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
271
AN:
3470
East Asian (EAS)
AF:
AC:
504
AN:
5148
South Asian (SAS)
AF:
AC:
1099
AN:
4782
European-Finnish (FIN)
AF:
AC:
904
AN:
10578
Middle Eastern (MID)
AF:
AC:
29
AN:
292
European-Non Finnish (NFE)
AF:
AC:
9574
AN:
67882
Other (OTH)
AF:
AC:
309
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.581
Heterozygous variant carriers
0
683
1365
2048
2730
3413
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
534
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Megalencephalic leukoencephalopathy with subcortical cysts 1 Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.